Comments

Innoviva Stock Price, Quotes and Forecasts

Q: What sector and industry does Innoviva (INVA) operate in?

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

INVANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$17.79

-0.13-0.73%

At close: -

$17.79

0.000.00%

After Hours: 4:00 PM EDT

Q4 2024 Earnings were released on Wed Feb 26th, after the market close

Innoviva (INVA) Forecast

News Earnings Innoviva (INVA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Innoviva Stock Price, Quotes and Forecasts | NASDAQ:INVA | Benzinga

Explore Innoviva stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INVA.

Open	$17.78
Close	$17.79
Volume / Avg.	640.86K / 571.17K
Day Range	$17.52 - $17.91
52 Wk Range	14.33 - 21.28
Market Cap	$1.11B
P/E Ratio	49.78
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	28.21%
Days to Cover	19.03

Recent News

Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs

Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products.

Vandana Singh

AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter

Vandana Singh

Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying

Although US stocks closed higher on Monday, there were a few notable insider trades.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.78
Close	$17.79
Volume / Avg.	640.86K / 571.17K
Day Range	$17.52 - $17.91
52 Wk Range	14.33 - 21.28
Market Cap	$1.11B
P/E Ratio	49.78
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	28.21%
Days to Cover	19.03

About Innoviva Inc

Sector

Health Care

Industry

Pharmaceuticals

Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has thr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Innoviva (INVA) stock?

You can purchase shares of Innoviva (NASDAQ:INVA) through any online brokerage.

View our list of the best stock brokerages

Who are Innoviva (INVA) competitors?

Other companies in Innoviva’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS) and Tarsus Pharmaceuticals (NASDAQ:TARS).

What is the forecast, or price target, for Innoviva (INVA) stock?

Innoviva has a consensus price target of $15.17.

What is the current price for Innoviva (INVA)?

The stock price for Innoviva (NASDAQ: INVA) is $17.79 last updated March 3, 2025 at 4:00 PM EST.

Does Innoviva (INVA) pay a dividend?

There are no upcoming dividends for Innoviva.

When is Innoviva (NASDAQ:INVA) reporting earnings?

Innoviva’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Innoviva (INVA) going to split?

There is no upcoming split for Innoviva.

What sector and industry does Innoviva (INVA) operate in?

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.